aTYR PHARMA (ATYR) Market Capitalization (2015 - 2026)

aTYR PHARMA (ATYR) has reported Market Capitalization for 12 consecutive years, with $58.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 87.5% year-over-year to $58.9 million; the trailing twelve-month figure through Jun 2026 stood at $58.9 million (down 87.5% YoY), and the FY2025 full-year result was $76.8 million, down 74.77% from the prior year.
• Market Capitalization eased to $58.9 million in Q2 2026 per ATYR's latest filing, from $76.5 million in the prior quarter.
• Across five years, Market Capitalization topped out at $470.9 million in Q2 2025 and bottomed at $58.9 million in Q2 2026.
• Historically, Market Capitalization has averaged $138.1 million across 5 years, with a median of $90.9 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization surged 298.21% in 2025, then tumbled 87.5% in 2026.
• Over 5 years, Market Capitalization stood at $64.6 million in 2022, then jumped by 38.13% to $89.2 million in 2023, then soared by 240.93% to $304.2 million in 2024, then sank by 74.77% to $76.8 million in 2025, then decreased by 23.34% to $58.9 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $58.9 million, $76.5 million, and $76.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.